Katherine Mangum

Katherine Mangum serves as a Program Officer responsible for overseeing the acquisition and management of research and development initiatives in the physical, engineering, and life sciences. In this role, she plays a critical part in translating scientific priorities into actionable procurement strategies, ensuring that federal research objectives are met through technically sound, competitively awarded contracts. Her work bridges programmatic needs with acquisition compliance, focusing on complex R&D services that require specialized scientific expertise and innovative methodologies. She typically handles task orders and basic ordering agreements for advanced scientific research, laboratory services, and engineering analysis, often involving multi-disciplinary teams and cutting-edge technical capabilities. While no specific contractor relationships are currently identifiable in the available data, Mangum’s procurement pattern indicates consistent engagement with firms possessing deep technical proficiency in experimental design, data analytics, and applied scientific research. She collaborates with a broad spectrum of vendors, including large primes, mid-tier engineering firms, and academic research contractors, prioritizing proposers with demonstrated capability in peer-reviewed scientific execution and regulatory compliance. Mangum’s contracting activity is entirely non-set-aside, reflecting a procurement strategy centered on technical merit and competitive best-value selection rather than socioeconomic preferences. This indicates a focus on mission-critical R&D outcomes where specialized expertise outweighs socioeconomic targeting, though she remains compliant with all federal small business participation requirements. Her primary NAICS focus—541712—demonstrates a dedicated specialization in physical, engineering, and life sciences research. She procures services such as laboratory testing, computational modeling, materials characterization, and clinical trial support, requiring contractors with advanced instrumentation, peer-reviewed research experience, and adherence to federal research standards. Her domain expertise lies at the intersection of scientific innovation and federal acquisition governance.